Continued Controversy on Chrysotile Biopersistence

References

• Donaldson K, Oberdörster G. Continued controversy on chrysotile biopersistence. Int J Occup Environ Health. 2011; 17 (1): 98–99.
   PubMed Web of Science ®Google Scholar
• Vorwald AJ, Durkan TM, Pratt PC. Experimental studies of asbestosis. AM A Arch Ind Hyg Occup Med. Jan 1951; 3 (1): 1–43.
   PubMedGoogle Scholar
• Hardy H, Egilman D. Corruption of occupational medical literature: The asbestos example. Am J Ind Med. 1991; 20 (1): 127–129.
   PubMed Web of Science ®Google Scholar
• Stanton MF, Layard M, Tegeris A, et al. Relation of particle dimension to car-cinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. Nov 1981;67(5) :965–975.
   PubMed Web of Science ®Google Scholar
• Donaldson K, Brown GM, Brown DM, Bolton RE, Davis JM. Inflammation generating potential of long and short fibre amosite asbestos samples. Br J Ind Med. Apr 1989; 46 (4): 271–276.
   PubMed Web of Science ®Google Scholar
• NIOSH. NIOSH criteria for a recommended standard: Occupational Exposure to Asbestos 1972.
   Google Scholar
• Lynch JR, Ayer HE, Johnson DL. The interrelationships of selected asbestos exposure indices. Am Ind Hyg Assoc J. Sep-Oct 1970; 31 (5): 598–604.
   PubMed Web of Science ®Google Scholar
• Egilman D. Fiber types, asbestos potency, and environmental causation: A peer review of published work and legal and regulatory scientific testi-mony. Int J Occup Environ Health. Apr-Jun 2009;15(2) :202–228.
   PubMed Web of Science ®Google Scholar
• Finkelstein MM, Dufresne A. Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers. Am J Ind Med. Apr 1999;35(4) :401–412.
   PubMed Web of Science ®Google Scholar
• Appel JD, Fasy TM, Kohtz DS, Kohtz JD, Johnson EM. Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA. Proc Natl Acad Sci USA. Oct 1988; 85 (20): 7670–7674.
   PubMed Web of Science ®Google Scholar
• Barrett JC. Cellular and molecular mechanisms of asbestos carcinogenicity: Implications for biopersistence. Environ Health Perspect. Oct 1994;102 Suppl 5: 19–23.
   PubMed Web of Science ®Google Scholar
• Walker C, Everitt J, Barrett JC. Possible cellular and molecular mechanisms for asbestos carcinogenicity. Am J Ind Med. 1992;21 (2) :253–273.
   PubMed Web of Science ®Google Scholar
• Warheit DB, Hartsky MA, Frame SR. Pulmonary effects in rats inhaling size-separated chrysotile asbestos fibres or p-aramid fibrils: Differences in cellular proliferative responses. Toxicol Lett. Nov 1996;88(1-3) :287–292.
   PubMed Web of Science ®Google Scholar
• Bernstein DM, Hoskins JA. The health effects of chrysotile: current perspective based upon recent data. Regul Tox-icol Pharmacol. Aug 2006; 45 (3): 252–264.
   PubMed Web of Science ®Google Scholar
• Bernstein D, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation: Final results through 1 year after cessation of exposure. Inhal Toxicol. Jan 2005; 17 (1): 1–14.
   PubMed Web of Science ®Google Scholar
• Miller BG, Searl A, Davis JM, et al. Influence of fibre length, dissolution and biopersistence on the production of mesothelioma in the rat peritoneal cavity. Ann Occup Hyg. Apr 1999; 43 (3): 155–166.
   PubMed Web of Science ®Google Scholar
• Searl A, Buchanan D, Cullen RT, Jones AD, Miller BG, Soutar CA. Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann Occup Hyg. Apr 1999; 43 (3): 143–153.
   PubMed Web of Science ®Google Scholar
• Hesterberg TW, Miller WC, Mast R, McConnell EE, Bernstein DM, Anderson R. Relationship between lung biop-ersistence and biological effects of man-made vitreous fibers after chronic inhalation in rats. Environ Health Per-spect. Oct 1994;102 Suppl 5: 133–137.
   PubMed Web of Science ®Google Scholar
• Egilman D, Roberts M. Re: Controlled use of asbestos. Int J Occup Environ Health. Jan-Mar 2004;10(1) :99–103.
   PubMed Web of Science ®Google Scholar
• Langer AM, Wolff MS, Rohl AN, Selikoff IJ. Variation of properties of chrysotile asbestos subjected to milling. J Toxicol Environ Health. Jan 1978; 4 (1): 173–188.
   PubMed Web of Science ®Google Scholar
• Dunnigan J, Nadeau D, Paradis D. Cytotoxic effects of aramid fibres on rat pulmonary macrophages: Comparison with chrysotile asbestos. Toxicol Lett. Mar 1984; 20 (3): 277–282.
   PubMed Web of Science ®Google Scholar
• Jaurand MC, Magne L, Bignon J. The significance of lysosomal enzyme release induced by asbestos. In: Brown RC, Gormley IP, Chamberlain M, Davies RE, eds. The in vitro effects of mineral dusts. London; New York: Academic Press; 1980.
   Google Scholar
• Bernstein DM, Chevalier J, Smith P. Comparison of calidria chrysotile asbestos to pure tremolite: Inhalation biopersistence and histopathology fol-lowing short-term exposure. Inhal Tox-icol. Dec 2003; 15 (14): 1387–1419.
   PubMed Web of Science ®Google Scholar
• Ilgren EB. Coalinga fibre: A shortfibre, amphibole-free chrysotile-Part 4: Further evidence for a lack of fibrogenic and tumorigenic activity. Indoor and Built Environment. May-Jun 2002; 11 (3) :171–177.
   Web of Science ®Google Scholar
• Pinkerton KE, Brody AR, McLaurin DA, et al. Characterization of three types of chrysotile asbestos after aerosolization. Environ Res. Jun 1983; 31 (1): 32–53.
   Google Scholar
• Roberts F, Mackinnon JL, Cherrie L, Burnett RA, Harper CM. Interobserver variability in analysis of asbestos fibres and asbestos bodies in human lung tissue. Med Sci Law. Apr 2004;44 (2): 151–159.
   PubMed Web of Science ®Google Scholar
• Ilgren EB. Concentration and morphology of amphibole minerals present in some sources of chrysotile. 2008 ASTM Johnson Conference; 2008; Burlington, Vermont.
   Google Scholar
• Donaldson K. The inhalation toxicology of p-aramid fibrils. Crit Rev Toxicol. 2009;39(6) :487–500.
   PubMed Web of Science ®Google Scholar